Published :
Tables : 43
Figures : 41
Category : Healthcare
No. of Pages : 210
Report Code : HC-U3358
Breast Imaging Market is estimated to value over CAGR of over 7.9% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated a report that provides an intricate analysis of Breast Imaging Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Breast Imaging Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Technological advancements, increased occurrence of breast cancer, rise in the screening programs along with symposiums and conferences emphasizing on creating awareness regarding the advantages of early diagnosis and screening are the primary contributors to the breast imaging market growth. Furthermore, increasing private and public investments for meeting the rising insistence for breast cancer screenings and improvements in reimbursement policies are some other factors responsible for the proliferation of the market. Market Segmentation: By Technology • Ionizing Breast Imaging o Mammography • Full-field Digital Mammography (FFDM) • 3D Breast Tomosynthesis • Analog Mammography o Positron Emission Tomography-Computed Tomography (PET-CT) o Molecular Breast Imaging (MBI) o Positron Emission Mammography (PEM) o Cone-beam Computed Tomography (CBCT) • Non-ionizing Breast Imaging o Breast Ultrasound o Breast MRI o Automated Whole-breast Ultrasound (AWBU) o Breast thermography o Electric Impedance Tomography o Optical Imaging By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa The market is fragmented into technology, and region. The technology segment is classified into non-ionizing breast imaging and ionizing breast imaging technologies. The non-ionizing breast imaging is predicted to proliferate during the forecasted period, and this can be credited to the benefits provided by non-ionizing technology like high sensitivity to small breast lesions and better creation of anatomical details. The ionizing breast imaging segment is divided into mammography, PET-CT, molecular breast imaging, positron emission mammography, cone beam computed tomography (CBCT). Regional Analysis: The North America region is expected to lead the market due to advancements in technologies that can help in early diagnosis of cancer tumor, increasing prevalence of breast cancer in the region owing to unhealthy lifestyle and a lack of awareness regarding the development of breast cancer. Competitive Landscape: Some of the prominent players are Hologic, Inc., GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies, Inc., Micrima Limited, CMR Naviscan Corporation, SuperSonic Imagine, Carestream Health. FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the global breast imaging market by technology and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated a report that provides an intricate analysis of Breast Imaging Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Breast Imaging Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Technological advancements, increased occurrence of breast cancer, rise in the screening programs along with symposiums and conferences emphasizing on creating awareness regarding the advantages of early diagnosis and screening are the primary contributors to the breast imaging market growth. Furthermore, increasing private and public investments for meeting the rising insistence for breast cancer screenings and improvements in reimbursement policies are some other factors responsible for the proliferation of the market.
Market Segmentation:
By Technology • Ionizing Breast Imaging o Mammography • Full-field Digital Mammography (FFDM) • 3D Breast Tomosynthesis • Analog Mammography o Positron Emission Tomography-Computed Tomography (PET-CT) o Molecular Breast Imaging (MBI) o Positron Emission Mammography (PEM) o Cone-beam Computed Tomography (CBCT) • Non-ionizing Breast Imaging o Breast Ultrasound o Breast MRI o Automated Whole-breast Ultrasound (AWBU) o Breast thermography o Electric Impedance Tomography o Optical Imaging
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
The market is fragmented into technology, and region. The technology segment is classified into non-ionizing breast imaging and ionizing breast imaging technologies. The non-ionizing breast imaging is predicted to proliferate during the forecasted period, and this can be credited to the benefits provided by non-ionizing technology like high sensitivity to small breast lesions and better creation of anatomical details. The ionizing breast imaging segment is divided into mammography, PET-CT, molecular breast imaging, positron emission mammography, cone beam computed tomography (CBCT).
Regional Analysis:
The North America region is expected to lead the market due to advancements in technologies that can help in early diagnosis of cancer tumor, increasing prevalence of breast cancer in the region owing to unhealthy lifestyle and a lack of awareness regarding the development of breast cancer.
Competitive Landscape:
Some of the prominent players are Hologic, Inc., GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies, Inc., Micrima Limited, CMR Naviscan Corporation, SuperSonic Imagine, Carestream Health.
FutureWise Key Takeaways:
• Growth prospects • SWOT analysis • Key market trends • Key data-points affecting market growth
Objectives of the Study:
• To provide with an exhaustive analysis on the global breast imaging market by technology and by region • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders 2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study 3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights 4. Breast Imaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Breast Imaging Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Breast Imaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Breast Imaging Market, By Technology Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1. Ionizing Breast Imaging 7.1.1. Mammography 7.1.1.1. Full-field Digital Mammography (FFDM) 7.1.1.2. 3D Breast Tomosynthesis 7.1.1.3. Analog Mammography 7.1.2. Positron Emission Tomography-Computed Tomography (PET-CT) 7.1.3. Molecular Breast Imaging (MBI) 7.1.4. Positron Emission Mammography (PEM) 7.1.5. Cone-beam Computed Tomography (CBCT) 7.2. Non-ionizing Breast Imaging 7.2.1. Breast Ultrasound 7.2.2. Breast MRI 7.2.3. Automated Whole-breast Ultrasound (AWBU) 7.2.4. Breast thermography 7.2.5. Electric Impedance Tomography 7.2.6. Optical Imagings 8. North America Breast Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 8.1. Introduction 8.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 8.2.1. U.S.A 8.2.2. Canada 8.2.3. Mexico 8.3. Market Size (USD Million) Forecast for North America 2022-2028 9. Latin America Breast Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. Brazil 9.2.2. Venezuela 9.2.3. Argentina 9.2.4. Rest of Latin America 9.3. Market Size (USD Million) Forecast for Latin America 2022-2028 10. Europe Breast Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Russia 10.2.7. Poland 10.2.7. Rest of Europe 10.3. Market Size (USD Million) Forecast for Europe 2022-2028 11. Asia Pacific Breast Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Japan 11.2.2. China 11.2.3. India 11.2.4. Australia and New Zealand 11.2.5. ASEAN 11.2.6. Rest of Asia Pacific 11.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 12. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. GCC 12.2.2. Israel 12.2.3. South Africa 12.2.4. Rest of MEA 12.3. Market Size (USD Million) Forecast for MEA 2022-2028 13. Market Share Analysis and Competitive Landscape 13.1. Global Landscape - Key Players, Revenue and Presence 13.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 13.3. Global Emerging Companies 13.4. North America - Market Share Analysis and Key Regional Players 13.5. Europe - Market Share Analysis and Key Regional Players 13.6. Asia Pacific - Market Share Analysis and Key Regional Players 13.7. Global Key Player - Growth Matrix 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 14.1 Canon Inc. 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Aurora Healthcare US Corp. 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 FUJIFILM Medical Systems U.S.A. 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 GE Healthcare 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Allengers 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Dilon Technologies Inc. 14.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7 Planmed Oy 14.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8 Delphinus Medical Technologies Inc. 14.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9 Micrima Limited 14.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10 Koninklijke Philips N.V. 14.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11 Siemens Healthineers 14.11.1. Company Overview (HQ, Business Segments, Employee Strength) 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 15. Pre and Post COVID-19 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1. Objectives of the Study 1.2. Market Definition 1.3. Market Scope 1.3.1. Years Considered for the Study 1.3.2. Market Covered 1.4. Currency 1.5. Limitations 1.6. Stakeholders
2. Research Methodology 2.1. Research Data 2.1.1. Secondary Data 2.1.1.1. Key Data from Secondary Sources 2.1.2. Primary Data 2.1.2.1. Key Data from Primary Sources 2.2. Market Size Estimation 2.3. Market Breakdown and Data Triangulation 2.4. Assumptions for the Study
3. Executive Summary 3.1. Market Outlook 3.2. Segment Outlook 3.3. Competitive Insights
4. Breast Imaging Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Breast Imaging Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Breast Imaging Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Breast Imaging Market, By Technology Historical Analysis 2016 to 2020 and Forecast 2022-2028 (USD million) 7.1. Ionizing Breast Imaging 7.1.1. Mammography 7.1.1.1. Full-field Digital Mammography (FFDM) 7.1.1.2. 3D Breast Tomosynthesis 7.1.1.3. Analog Mammography 7.1.2. Positron Emission Tomography-Computed Tomography (PET-CT) 7.1.3. Molecular Breast Imaging (MBI) 7.1.4. Positron Emission Mammography (PEM) 7.1.5. Cone-beam Computed Tomography (CBCT) 7.2. Non-ionizing Breast Imaging 7.2.1. Breast Ultrasound 7.2.2. Breast MRI 7.2.3. Automated Whole-breast Ultrasound (AWBU) 7.2.4. Breast thermography 7.2.5. Electric Impedance Tomography 7.2.6. Optical Imagings
8. North America Breast Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 8.1. Introduction 8.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 8.2.1. U.S.A 8.2.2. Canada 8.2.3. Mexico 8.3. Market Size (USD Million) Forecast for North America 2022-2028
9. Latin America Breast Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 9.2.1. Brazil 9.2.2. Venezuela 9.2.3. Argentina 9.2.4. Rest of Latin America 9.3. Market Size (USD Million) Forecast for Latin America 2022-2028
10. Europe Breast Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5. Spain 10.2.6. Russia 10.2.7. Poland 10.2.7. Rest of Europe 10.3. Market Size (USD Million) Forecast for Europe 2022-2028
11. Asia Pacific Breast Imaging Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 11.2.1. Japan 11.2.2. China 11.2.3. India 11.2.4. Australia and New Zealand 11.2.5. ASEAN 11.2.6. Rest of Asia Pacific 11.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
12. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 12.2.1. GCC 12.2.2. Israel 12.2.3. South Africa 12.2.4. Rest of MEA 12.3. Market Size (USD Million) Forecast for MEA 2022-2028
13. Market Share Analysis and Competitive Landscape 13.1. Global Landscape - Key Players, Revenue and Presence 13.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 13.3. Global Emerging Companies 13.4. North America - Market Share Analysis and Key Regional Players 13.5. Europe - Market Share Analysis and Key Regional Players 13.6. Asia Pacific - Market Share Analysis and Key Regional Players 13.7. Global Key Player - Growth Matrix
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 14.1 Canon Inc. 14.1.1. Company Overview (HQ, Business Segments, Employee Strength) 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2 Aurora Healthcare US Corp. 14.2.1. Company Overview (HQ, Business Segments, Employee Strength) 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3 FUJIFILM Medical Systems U.S.A. 14.3.1. Company Overview (HQ, Business Segments, Employee Strength) 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4 GE Healthcare 14.4.1. Company Overview (HQ, Business Segments, Employee Strength) 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Allengers 14.5.1. Company Overview (HQ, Business Segments, Employee Strength) 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6 Dilon Technologies Inc. 14.6.1. Company Overview (HQ, Business Segments, Employee Strength) 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7 Planmed Oy 14.7.1. Company Overview (HQ, Business Segments, Employee Strength) 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8 Delphinus Medical Technologies Inc. 14.8.1. Company Overview (HQ, Business Segments, Employee Strength) 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9 Micrima Limited 14.9.1. Company Overview (HQ, Business Segments, Employee Strength) 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10 Koninklijke Philips N.V. 14.10.1. Company Overview (HQ, Business Segments, Employee Strength) 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11 Siemens Healthineers 14.11.1. Company Overview (HQ, Business Segments, Employee Strength) 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview
15. Pre and Post COVID-19 Impact 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations
16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics